Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
-
841
The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
842
The trends in the expression of inflammation-related genes in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
843
The Fibrosis scoring by Sirius Red staining and SHG/TPEF.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
844
Effects of Kylo-0603 on body weight, organ weight, and body fat content.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
845
The trends in the expression of fibrosis-related genes in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
846
Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
847
-
848
General procedure for the synthesis of A and A-c1.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
849
Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603...
Published 2025Subjects: “…attenuates fibrosis progression…”
-
850
-
851
Trends of peroxisome-related gene expression in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
852
NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day).
Published 2025Subjects: “…attenuates fibrosis progression…”
-
853
The body weight and cholesterol levels of the mice were recorded before the administration of the drug.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
854
Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine...
Published 2025Subjects: “…attenuates fibrosis progression…”
-
855
General procedure for the synthesis of Kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
856
-
857
-
858
-
859
-
860